BLUE Price Targets and Analyst Ratings NASDAQ:BLUE
BLUE Forecast. What You Should Know.
BLUE Historical Ratings and Targets
About bluebird bio
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clini... BLUE Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.